NEUTRON ROW has a total of 15 patent applications. Its first patent ever was published in 2009. It filed its patents most often in Australia, Canada and China. Its main competitors in its focus markets pharmaceuticals are FIDES LAB, KANEHIDE BIO KK and VIVACQUA MARCELO.
# | Country | Total Patents | |
---|---|---|---|
#1 | Australia | 1 | |
#2 | Canada | 1 | |
#3 | China | 1 | |
#4 | Colombia | 1 | |
#5 | Costa Rica | 1 | |
#6 | Ecuador | 1 | |
#7 | EPO (European Patent Office) | 1 | |
#8 | Israel | 1 | |
#9 | Republic of Korea | 1 | |
#10 | Mexico | 1 | |
#11 | Nicaragua | 1 | |
#12 | New Zealand | 1 | |
#13 | Ukraine | 1 | |
#14 | WIPO (World Intellectual Property Organization) | 1 | |
#15 | South Africa | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations |
# | Name | Total Patents |
---|---|---|
#1 | Evans-Freke Stephen | 10 |
#2 | Evans Freke Stephen | 2 |
#3 | Stephen Evans-Freke | 2 |
Publication | Filing date | Title |
---|---|---|
UA102098C2 | Use of corticotropin-releasing factor for the treatment of cancer | |
CN102036680A | Methods of using corticotropin-releasing factor for the treatment of cancer |